Company Search:
Advanced Search
Sponsored Links
Golden Leaf Holdings Ltd Company Snapshot
Golden Leaf Holdings Ltd operates in the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Golden Leaf Holdings Ltd with three other pharmaceutical manufacturers in North America: Adma Biologics Inc of the United States (2018 sales of $16.99 million of which 59% was Plasma Collection Center), Acceleron Pharma Inc of the United States ($13.99 million of which 100% was Bio-pharmaceutical), and Champions Oncology Inc which is also based in the United States ($20.24 million ).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Golden Leaf Holdings Ltd
  Stock Performance Chart for Golden Leaf Holdings Ltd
  Stock Data: Recent Stock Performance:
  Current Price (8/16/2019): .06
(Figures in Canadian Dollars)
1 Week 0.0%   13 Weeks 0.0%  
4 Weeks -50.0%   52 Weeks -74.4%  
Golden Leaf Holdings Ltd Key Data:
  Ticker: GLH Country: Canada
  Exchanges: VEN Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2018 Sales 21,379,470
(Year Ending Jan 2019).
Employees: N/A
  Currency: Canadian Dollars Market Cap: 7,618,107
  Fiscal Yr Ends: December Shares Outstanding: 138,511,038
  Share Type: Ordinary Closely Held Shares: 125,264,998
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.